Investment House LLC Sells 4,795 Shares of Agilent Technologies, Inc. $A

Investment House LLC reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 58.5% during the 3rd quarter, Holdings Channel reports. The fund owned 3,400 shares of the medical research company’s stock after selling 4,795 shares during the period. Investment House LLC’s holdings in Agilent Technologies were worth $586,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Lmcg Investments LLC grew its position in shares of Agilent Technologies by 6.2% in the third quarter. Lmcg Investments LLC now owns 105,340 shares of the medical research company’s stock valued at $18,151,000 after purchasing an additional 6,117 shares during the last quarter. Cardinal Capital Management lifted its holdings in Agilent Technologies by 3.8% during the 3rd quarter. Cardinal Capital Management now owns 78,054 shares of the medical research company’s stock worth $13,449,000 after purchasing an additional 2,854 shares during the last quarter. Axxcess Wealth Management LLC acquired a new stake in Agilent Technologies during the 3rd quarter worth approximately $894,000. Albion Financial Group UT lifted its holdings in Agilent Technologies by 1.7% during the 3rd quarter. Albion Financial Group UT now owns 10,328 shares of the medical research company’s stock worth $1,780,000 after purchasing an additional 168 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its stake in Agilent Technologies by 0.6% in the 3rd quarter. Quadrant Capital Group LLC now owns 12,508 shares of the medical research company’s stock valued at $2,146,000 after purchasing an additional 77 shares during the period.

Agilent Technologies Stock Performance

A opened at $172.98 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $179.10. The firm has a market cap of $48.77 billion, a P/E ratio of 28.69, a price-to-earnings-growth ratio of 2.65 and a beta of 1.21. The business’s fifty day moving average is $161.48 and its 200-day moving average is $139.62.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. Agilent Technologies’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be issued a $0.2550 dividend. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Citigroup boosted their price target on Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. HSBC increased their price objective on Agilent Technologies from $165.00 to $175.00 and gave the stock a “buy” rating in a research report on Tuesday, September 1st. Stifel Nicolaus lifted their target price on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. The Goldman Sachs Group boosted their target price on shares of Agilent Technologies from $175.00 to $185.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Finally, Piper Sandler boosted their target price on shares of Agilent Technologies from $150.00 to $160.00 and gave the company a “neutral” rating in a research report on Friday, August 28th. Seventeen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $181.00.

Insider Buying and Selling

In other news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.